Donate now

Gary Clifford Deputy Branch Head
Early Detection Prevention and Infections

Speciality: Epidemiology
Year Degree Major Institution Country/Town
1998 PhD Biological sciences University of Newcastle / Tyne UK / Newcastle upon Tyne
1994 Bachelor of Science (IIi Honors) Biological sciences University of Manchester UK / Manchester
Current Research Projects

Infection-attributable disease burden: local and global.

Evaluation of human papillomavirus (HPV) vaccine programme impact in various low- and middle-income country implementation settings.

HIV and cervical cancer epidemiology: burden and prevention in the combined antiretroviral therapy (cART) era in sub-Saharan Africa.

Anal cancer risk stratification assessment & implications for prevention.

Selected Publications

de Martel C, Georges D, Bray F, Ferlay J, Clifford GM. (2020) Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob Health 8: e180-e90

Debeaudrap P, Sobngwi J, Tebeu PM, Clifford GM. (2019) Residual or recurrent precancerous lesions after treatment of cervical lesions in HIV-infected women: a systematic review and meta-analysis of treatment failure. Clin Infect Dis 69(9): 1555-1565

Lin C, Slama J, Gonzalez P, Goodman MT, Xia N, Kreimer AR, […], Clifford GM. (2019) Cervical determinants of anal HPV infection and high-grade anal lesions in women: a collaborative pooled analysis. Lancet Infect Dis 19(8): 880-891

Lin C, Franceschi S, Clifford GM. (2018) Human papillomavirus types from infection to cancer in the anus, according to sex and HIV status: a systematic review and meta-analysis. Lancet Infect Dis 18: 198-206

Mpunga T, Znaor A, Uwizeye FR, Uwase A, Munyanshongore C, Franceschi S, Clifford GM. (2018) A case-control study of HIV infection and cancer in the era of antiretroviral therapy in Rwanda. Int J Cancer 143: 1348-55

Close Reading Mode
Publication status

Published in section: WHO'S WHO

Publication date: 19 July, 2018, 11:21

Direct link:

© Copyright International Agency on Research for Cancer 2024